Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Study of Plasmodium Immunotherapy for Advanced Breast Cancers and Advanced Liver Cancers

NCT03474822 is registered in ClinicalTrials.gov with CAS Lamvac Biotech Co., Ltd. as lead sponsor.

NCT NCT03474822
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03474822 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Study of Plasmodium Immunotherapy for Advanced Breast Cancers and Advanced Liver Cancers
Lead sponsor
CAS Lamvac Biotech Co., Ltd.
Phase
Phase 1/2
Overall status
Unknown status
Start date
August 10, 2018
Completion date
June 30, 2026
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

advanced breast cancer, advanced liver cancer